Sign in Pull a receipt

ANIP

ANI PHARMACEUTICALS INC

Pharmaceuticals · Pharmaceuticals

$277.49 sample

+4.63 (+1.70%) 1D

Market cap

$1.07T

Price as of

2026-10-29

Latest filing

8-K · 2026-09-25

Alerts

8

Price$277.49 +3.28% 3M daily closessample

281.54264.84

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider buy: Chief Executive Officer
Oct 16INSInsider buy: Director
Oct 13INSInsider sell: EVP, Operations
Oct 02INSInsider sell: EVP, Operations
Sep 25SECForm 144 filed
Sep 22INSInsider sell: 10% owner
Sep 17INSInsider buy: General Counsel
Sep 14SECDEF 14A filed

Sign up to see the real ANIP record →

Company facts

SEC EDGAR registration

Name: ANI PHARMACEUTICALS INC
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: -55sample, -100 to +100
Reporting currency: USD

Who is positioning in ANIP

sample

Insiders: 6 insider transactions over 90 days, net selling, $710.1M
Congress: 1 members traded over 90 days
Institutions · 13F: 36 funds hold $10.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$47.0B +14.5% y/y

Q4 2024Q3 2026

Inventory$29.3B +12.3% y/y

Q4 2024Q3 2026

Accounts receivable$21.2B +12.5% y/y

Q4 2024Q3 2026

Total debt$57.0B +12.1% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $224.2B +9.1% 3M
Sample peer B: $885.9B -9.9% 3M
Sample peer C: $937.6B +2.0% 3M
Sample peer D: $623.5B +8.0% 3M
Sample peer E: $696.3B -1.9% 3M